aMoon

aMoon is a leading Israeli life sciences venture fund. Our team is passionate about building successful businesses and helping Israeli biopharma, digital health and medical technology companies realize their potential.

Author: gilrabbi

Computational Pathology Pioneer Ibex Raises $11M

Posted on March 26, 2019December 28, 2020Author gilrabbiCategories News

Israeli migraine device co Theranica raises $35m

Posted on March 18, 2019December 28, 2020Author gilrabbiCategories News

Ayala Pharmaceuticals to Present Preclinical Data at AACR for AL101, a Pan-Notch Inhibitor Being Evaluated for Adenoid Cystic Carcinoma

Posted on March 6, 2019December 28, 2020Author gilrabbiCategories News

A healthcare investment fund has become one of Israel’s largest with a $660 million close

Posted on March 6, 2019December 28, 2020Author gilrabbiCategories News

Israeli health fund aMoon II raises $660 million

Posted on March 6, 2019December 28, 2020Author gilrabbiCategories News

Israeli firm creates particles to kill germs on contact, fight bacterial disease

Posted on August 2, 2018December 28, 2020Author gilrabbiCategories News

Zebra Medical Vision gets $30M Series C to create AI-based tools for radiologists

Posted on June 7, 2018December 28, 2020Author gilrabbiCategories News

Medial EarlySign’s clinical validation trial shows promise for detecting colorectal cancer

Posted on April 17, 2018December 28, 2020Author gilrabbiCategories News

BiondVax, NIAID kick off phase 2 universal flu vaccine study in U.S.

Posted on April 11, 2018December 28, 2020Author gilrabbiCategories News

Ayala notches up $17M in financing to push BMS drug into phase 2

Posted on April 10, 2018December 28, 2020Author gilrabbiCategories News

Posts pagination

Previous page Page 1 … Page 8 Page 9 Page 10 Next page
Contact Careers terms of service privacy policy
aMoon on linkedin aMoon on linkedin aMoon on twitter aMoon on twitter aMoon on youtube aMoon on youtube
Ra'anana, Israel
© aMoon Website by nym. Developed by Rabbi Interactive